We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug News
    • Trending
    • Commercial Operations
    • GMPs
    • FDA Enforcement Actions
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Drug Weekly
    • FDAnews
  • Device News
    • Trending
    • Commercial Operations
    • FDA Enforcement Actions
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Device Weekly
    • FDAnews
  • Books
    • FDAnews Books Library
    • Drug Books
    • Device Books
  • Training/Events
    • Webinar Training Pass
    • Events
  • Resources
    • Form 483s Database
    • FDA Approved Drugs
    • eCFR and Guidances
    • White Papers
  • CenterWatch
  • About Us
    • The Company
    • FDAnews Editorial Board
    • Contact Us
  • Advertising
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Webinar Recordings » Medical Product Advertising & Promotion - Webinar Recording/Transcript

Other Options

Audio Recording/Transcript - Jan. 24, 2018

$287.00

Audio Recording/Transcript - Jan. 24, 2018

$258.00

Audio Recording/Transcript - Jan. 24, 2018

$244.00

Audio Recording/Transcript - Jan. 24, 2018

$230.00

Audio Recording/Transcript - Jan. 24, 2018

$215.00

Medical Product Advertising & Promotion - Webinar Recording/Transcript

$287.00
Webinar Recordings

Product Details

Medical Product Advertising & Promotion: Social Media Do's and Don'ts

Social media is a two-edged sword — a boon for getting your message out, a magnet for warning letters should you run afoul of the FDA.

And other agencies are watching your social media behavior too — the FTC and the CPSC, to name two. Time to consult a lawyer? Or simply ...

Two of Washington’s top lawyers specializing in the intersection of social media and federal regulation discuss:

  • Common social media mistakes that trigger warning letters
  • How to deal with misleading, untruthful and/or biased posts
  • FDA enforcement activities to date
  • Use of social media for adverse event reporting and product improvement
  • Likely FDA moves that could affect your use of social media
  • And much more!

Your presenters, Naomi J.L. Halpern Esq. and Georgia C. Ravitz Esq., are experts at the Washington headquarters of Arent Fox LLP. Spend 90 minutes picking their brains — without paying one cent extra in billable hours.

FDA guidances set the social media rules, but also offer useful help — managing your social media presence, for public disclosures for sharing marketing and off-label information, and dealing with damaging information posted on social media.

Social media will only grow more central to your marketing and communications. But it’s a legal minefield too, best navigated with the help of expert lawyers. That’s reason enough to take part in this timely presentation.

  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing